Suchergebnisse - "Drug Therapy, Combination"

PubPharm (710)

11

SAFFRON-103 : a phase Ib study of sitravatinib plus tislelizumab in anti-PD-(L)1 refractory/resistant advanced melanoma

enthalten in: Immunotherapy | 2024

von Wang, X. | Pan, H. | Cui, J. | +9

12

Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer

enthalten in: Journal for immunotherapy of cancer | 2024

von Takei, S. | Tanaka, Y. | Lin, Y. | +21

13

Salmonella-mediated methionine deprivation drives immune activation and enhances immune checkpoint blockade therapy in melanoma

enthalten in: Journal for immunotherapy of cancer | 2024

von Zhou, S. | Zhang, S. | Zheng, K. | +7

14

LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy

enthalten in: Journal for immunotherapy of cancer | 2024

von Sun, L. | Ma, Z. | Zhao, X. | +7

15

Reconstruction of unreported subgroup survival data with PD-L1-low expression in advanced/metastatic triple-negative breast cancer using innovative KMSubtraction workflow

enthalten in: Journal for immunotherapy of cancer | 2024

von Li, Y. | Liang, X. | Li, H. | +1

16

Comparative Effect of Glucose-Lowering Drugs for Type 2 Diabetes Mellitus on Stroke Prevention: A Systematic Review and Network Meta-Analysis

in: Diabetes & Metabolism Journal | 2024

von Ji Soo Kim | Gyeongsil Lee | Kyung-Il Park | +1

17

Initial Combination Therapy in Type 2 Diabetes

in: Endocrinology and Metabolism | 2024

von Ji Yoon Kim | Nam Hoon Kim

18

M1 macrophages induce PD-L1hi cell-led collective invasion in HPV-positive head and neck squamous cell carcinoma via TNF-α/CDK4/UPS14

enthalten in: Journal for immunotherapy of cancer | 2023

von Wu, J. | Pang, X. | Yang, X. | +7

19

Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors

enthalten in: Journal for immunotherapy of cancer | 2023

von Bauer, T. | Santoro, A. | Lin, C. | +16

20

Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus : A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension

enthalten in: Diabetes & metabolism journal | 2023

von Moon, J. | Park, I. | Kim, H. | +12